作为结核病亚单元疫苗输送系统的酸性pH敏感脂质体:脂质体组成对细胞先天免疫反应的影响
M M Szachniewicz1, K E van Meijgaarden1, E Kavrik2
1Leiden University Center for Infectious Diseases (LUCID), Leiden University Medical Center (LUMC), The Netherlands.
International immunopharmacology
|December 8, 2024
概括
对pH敏感的脂质体有效地传递结核病 (TB) 疫苗抗原,促进CD8+ T细胞的反应. 这种新型的输送系统显示出开发新型结核病疫苗的前景.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
- 纳米技术 纳米技术
背景情况:
- 结核病 (TB) 仍然是一个重大的全球卫生挑战,需要新的疫苗策略.
- CD8+ T细胞与CD4+ T细胞一起,对抗结核病的保护性免疫是至关重要的.
- 对pH敏感的脂质体提供了一种潜在的机制,通过抗原呈现来增强CD8+T细胞的反应.
研究的目的:
- 评估pH敏感脂质体作为多阶段蛋白质子单元结核病疫苗的输送系统.
- 评估脂肪体疫苗在人类初级细胞中的免疫性.
主要方法:
- 使用融合抗原Ag85b-ESAT6-Rv2034 (AER) 制备pH敏感脂质体.
- 在人体单细胞衍生树突细胞 (MDDCs) 中对脂质体吸收,细胞活力和激活标记表达的体外评估.
- 评价细胞因子生产 (CCL3,CCL4,TNFα) 和T细胞激活 (CD154,IFNγ) 作为对脂质体疫苗的反应.
主要成果:
- 脂质体在MDDCs中表现出有效的细胞吸收和诱导激活标记物.
- 脂质体疫苗配方刺激了MDDC中关键细胞因子 (CCL3,CCL4,TNFα) 的产生.
- 观察到人类T细胞的抗原特异性激活,对CD154和IFNγ进行上调.
结论:
- 阴离子pH敏感脂质体在输送结核病疫苗抗原方面是有效的.
- 这种脂质体疫苗平台引起了强大的Mycobacterium结核病 (Mtb) 特定的免疫反应.
- 对pH敏感的脂质体是开发先进结核病疫苗接种策略的有希望的候选者.
更多相关视频
06:32Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
10.6K
06:26Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
2.1K
相关概念视频
Defense Against Bacterial Pathogens
1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Pulmonary Tuberculosis II
211
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
211
